ADIL Market Cap History
Below is a table of the ADIL market cap history going back to 7/27/2018:

Date ADIL Market Cap
7/27/201826.63M
9/6/201819.01M
11/13/20188.33M
2/15/201930.36M

Also see: ADIL Shares Outstanding History
and ADIL YTD Return
ADIL Historical Market Cap:
+25.23% CAGR
ADIL Historical Market Cap: +25.23% CAGR

Mouse over chart for data details
7/27/20189/6/201811/13/20182/15/2019
Adial Pharmaceuticals is a clinical-stage biopharmaceutical company, focuses on the development of therapeutic agents for the treatment of alcohol use disorders in the United States. Co.'s lead product is AD04, a selective serotonin-3 antagonist that has completed Phase IIb clinical trials for the treatment of nausea and emesis. We show 4 historical shares outstanding datapoints in our ADIL shares outstanding history coverage, used to compute ADIL market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ADIL market cap history over the course of time is important for investors interested in comparing ADIL's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ADIL versus a peer is one thing; comparing ADIL market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ADIL can fluctuate over the course of history. With this page we aim to empower investors researching ADIL by allowing them to research the ADIL market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for ADIL:
ADIL SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
ADial Pharmaceuticals (ADIL) is categorized under the Miscellaneous sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ADNT Market Cap History
AEYE Market Cap History
AFIN Market Cap History
AFMD Market Cap History
AGMH Market Cap History
AGS Market Cap History
AHPA Market Cap History
AIHS Market Cap History
AIPT Market Cap History
AIRR Market Cap History
More Miscellaneous companies »

 

ADIL Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2019, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.